S21-307 Valency Controlled Receptor Systems for Cell Engineering and Therapy Stanford Reference: 21-307 & 20-066 Lei Qi Paul Finn
S22-275 Composition and Method of Universal Programmable Virus-like Particles (VLPs) Stanford researchers have engineered retroviral and virus-like delivery systems for producing universal pseudotyped vehicles for cell and gene therapies. Lei Qi Michael Chavez Paul Finn